MD
Income statement / Annual
Last year (2024), Pediatrix Medical Group, Inc.'s total revenue was $2.01 B,
an increase of 0.92% from the previous year.
In 2024, Pediatrix Medical Group, Inc.'s net income was -$103.61 M.
See Pediatrix Medical Group, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.01 B |
$1.99 B |
$1.97 B |
$1.91 B |
$1.73 B |
$3.51 B |
$3.65 B |
$3.46 B |
$3.18 B |
$2.78 B |
| Cost of Revenue |
$0.00
|
$1.57 B
|
$1.50 B
|
$1.40 B
|
$1.28 B
|
$2.62 B
|
$2.66 B
|
$2.46 B
|
$2.15 B
|
$1.85 B
|
| Gross Profit |
$2.01 B
|
$421.57 M
|
$467.03 M
|
$513.24 M
|
$449.32 M
|
$892.00 M
|
$989.51 M
|
$1.00 B
|
$1.03 B
|
$928.01 M
|
| Gross Profit Ratio |
1
|
0.21
|
0.24
|
0.27
|
0.26
|
0.25
|
0.27
|
0.29
|
0.32
|
0.33
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$238.44 M
|
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$404.64 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$238.44 M
|
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$404.64 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
| Other Expenses |
$1.84 B
|
$186.70 M
|
$35.64 M
|
$32.15 M
|
$28.44 M
|
$78.86 M
|
$111.28 M
|
$102.88 M
|
$89.26 M
|
$64.23 M
|
| Operating Expenses |
$2.08 B
|
$414.24 M
|
$267.03 M
|
$295.50 M
|
$277.39 M
|
$483.50 M
|
$543.66 M
|
$519.98 M
|
$461.84 M
|
$370.14 M
|
| Cost And Expenses |
$2.08 B
|
$1.99 B
|
$1.77 B
|
$1.69 B
|
$1.56 B
|
$3.11 B
|
$3.20 B
|
$2.98 B
|
$2.61 B
|
$2.22 B
|
| Interest Income |
$0.00
|
$0.00
|
$3.67 M
|
$13.65 M
|
$17.91 M
|
$3.69 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$40.74 M
|
$42.08 M
|
$39.70 M
|
$68.72 M
|
$110.48 M
|
$119.38 M
|
$88.77 M
|
$74.56 M
|
$63.09 M
|
$23.11 M
|
| Depreciation & Amortization |
$32.23 M
|
$36.17 M
|
$35.64 M
|
$32.15 M
|
$28.44 M
|
$25.93 M
|
$83.83 M
|
$102.88 M
|
$89.26 M
|
$64.23 M
|
| EBITDA |
-$28.37 M |
$29.89 M |
$235.64 M |
$249.89 M |
$200.37 M |
$258.58 M |
$527.69 M |
$587.86 M |
$660.95 M |
$622.10 M |
| EBITDA Ratio |
-0.01
|
0.01
|
0.12
|
0.13
|
0.12
|
0.14
|
0.15
|
0.17
|
0.21
|
0.22
|
| Operating Income Ratio |
-0.03
|
0
|
0.09
|
0.11
|
0.1
|
0.12
|
0.12
|
0.14
|
0.18
|
0.2
|
| Total Other Income/Expenses Net |
-$32.63 M
|
-$55.68 M
|
-$91.32 M
|
-$67.69 M
|
-$90.98 M
|
-$112.97 M
|
$120.45 M
|
-$69.65 M
|
-$57.89 M
|
-$18.14 M
|
| Income Before Tax |
-$101.34 M
|
-$48.36 M
|
$81.37 M
|
$135.23 M
|
$7.15 M
|
-$1.24 B
|
$368.84 M
|
$410.42 M
|
$513.80 M
|
$539.73 M
|
| Income Before Tax Ratio |
-0.05
|
-0.02
|
0.04
|
0.07
|
0
|
-0.35
|
0.1
|
0.12
|
0.16
|
0.19
|
| Income Tax Expense |
-$2.27 M
|
$12.05 M
|
$18.81 M
|
$27.24 M
|
$16.73 M
|
-$91.89 M
|
$100.21 M
|
$90.05 M
|
$189.20 M
|
$204.04 M
|
| Net Income |
-$103.61 M
|
-$60.41 M
|
$66.34 M
|
$130.96 M
|
-$9.58 M
|
-$1.15 B
|
$268.63 M
|
$320.37 M
|
$324.91 M
|
$336.32 M
|
| Net Income Ratio |
-0.05
|
-0.03
|
0.03
|
0.07
|
-0.01
|
-0.33
|
0.07
|
0.09
|
0.1
|
0.12
|
| EPS |
-1.24 |
-0.72 |
0.79 |
1.54 |
-0.11 |
-13.77 |
2.95 |
3.42 |
3.47 |
3.59 |
| EPS Diluted |
-1.24 |
-0.73 |
0.79 |
1.53 |
-0.11 |
-13.77 |
2.93 |
3.42 |
3.47 |
3.58 |
| Weighted Average Shares Out |
$83.33 M
|
$84.02 M
|
$83.47 M
|
$84.83 M
|
$83.40 M
|
$83.50 M
|
$91.10 M
|
$92.43 M
|
$92.42 M
|
$93.74 M
|
| Weighted Average Shares Out Diluted |
$83.33 M
|
$82.20 M
|
$84.12 M
|
$85.83 M
|
$83.40 M
|
$83.50 M
|
$91.61 M
|
$93.72 M
|
$93.72 M
|
$93.96 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
